{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:17:14Z","timestamp":1789435034451,"version":"build-2803163510"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T00:00:00Z","timestamp":1230681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Nearly three decades after its discovery, HIV infection remains the number one killer disease in Sub-Saharan Africa where up to 67% of the world\u2019s 33 million infected people live. In Cameroon, based on a Demographic Health Survey carried out in 2004, the national HIV prevalence is estimated at 5.5% with women and youths being predominantly infected. Orphans and vulnerable children (OVC) from the HIV and AIDS pandemic have increased steadily over the years; hospital occupancy is estimated at about 30%, hence stretching the health system; co-infections like HIV\/tuberculosis have been reported to reach 40-50% of infected cases and 95% of teachers are said not to be productive on several counts. Thus, the impact is multi-sectorial. Furthermore, the HIV epidemic in Cameroon is peculiar because of the wide HIV-1 genetic diversity of HIV-1 Group M observed with several subtypes reported (A, B, C, D, F, G, H, J, K), predominantly subtype A. There are also circulating recombinant forms, mainly CRF02_AG. In addition, HIV-1 Groups O and N have all been noted in Cameroon. These findings have great implications not only for HIV diagnosis, but also for responsiveness to therapy as well as for vaccine development. In 1986, the initial response of the Cameroon government to the increasing trends in the HIV\/AIDS infection was to create a National AIDS Control Committee to coordinate a national AIDS programme. By 2000, the first National Strategic Plan was drawn for 2000-2005. The second National Strategic Plan for 2006-2010 is currently being implemented and covers various axes. Some results obtained show that there has been significantly positive outcomes noted in the various arms of intervention by the Cameroon government.<\/jats:p>","DOI":"10.3390\/ijerph5050378","type":"journal-article","created":{"date-parts":[[2008,12,28]],"date-time":"2008-12-28T09:09:16Z","timestamp":1230455356000},"page":"378-383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Current Status of HIV\/AIDS in Cameroon: How Effective are Control Strategies?"],"prefix":"10.3390","volume":"5","author":[{"given":"Dora","family":"Mbanya","sequence":"first","affiliation":[{"name":"Faculty of Medicine & Biomedical Sciences, University of Yaound\u00e9 I, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Sama","sequence":"additional","affiliation":[{"name":"Tropical Medicine Research Center, Kumba, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Tchounwou","sequence":"additional","affiliation":[{"name":"Jackson State University, Jackson, Mississippi, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2008,12,31]]},"reference":[{"key":"ref_1","unstructured":"(2008). 2008 Report on the global HIV\/AIDS epidemic, UNAIDS\/WHO."},{"key":"ref_2","unstructured":"(2007). 2007 Report on the global HIV\/AIDS epidemic, UNAIDS\/WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/JCM.40.3.837-845.2002","article-title":"Human immunodeficiency virus type 1 group M protease in Cameroon: genetic diversity and protease inhibitor mutational features","volume":"40","author":"Fonjungo","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/00126334-200412150-00019","article-title":"Genetic diversity of HIV type 1 in rural eastern Cameroon","volume":"37","author":"Ndembi","year":"2004","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/aid.2006.22.812","article-title":"HIV genetic diversity in Cameroon: possible public health importance","volume":"22","author":"Ndongmo","year":"2006","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.qai.0000226793.16216.55","article-title":"Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural Western Cameroon","volume":"43","author":"Koizumi","year":"2006","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.00428-07","article-title":"Molecular characterization of HIV-1 and HIV-2 in Yaound\u00e9, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B","volume":"46","author":"Ndembi","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/jvi.68.3.1586-1596.1994","article-title":"Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency isolate","volume":"68","author":"Decourt","year":"1994","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1097\/00002030-199311000-00026","article-title":"Antigenic evidence of the presence of the abberant HIV-1 ANT 70 virus in Cameroon and Gabon","volume":"7","author":"Nkengasong","year":"1993","journal-title":"AIDS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/2017","article-title":"Identification of a new Human Immunodeficiency Virus type 1 Distinct from Group and Group O","volume":"4","author":"Simon","year":"1998","journal-title":"Nature Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1089\/0889222041217392","article-title":"Identification of a highly divergent HIV-2 and proposal for a change in HIV-2 classification","volume":"20","author":"Damond","year":"2004","journal-title":"AIDS Res. Human. Retrovir."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.1993.03510170073033","article-title":"Epidemiology and transmission of HIV-2: Why there is no HIV-2 pandemic","volume":"270","author":"DeCock","year":"1993","journal-title":"JAMA"},{"key":"ref_13","unstructured":"(2002). Minist\u00e8re de la Sant\u00e9 Publique (Cadre conceptuel du DIS viable),."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00042560-199805010-00015","article-title":"Trends of AIDS epidemic in Cameroon, 1986 through 1995","volume":"18","author":"Nkengasong","year":"1998","journal-title":"J. Acq. Immuno. Defic. Syndr. Hum. Retrovir."},{"key":"ref_15","first-page":"31","article-title":"Profil de l\u2019\u00e9pid\u00e9mie VIH\/SIDA au Cameroun","volume":"99","author":"Mvondo","year":"1992","journal-title":"Bull. Liais. Doc. OCEAC"},{"key":"ref_16","first-page":"5","article-title":"Review of HIV prevalence studies in Cameroon","volume":"1","author":"Abbenyi","year":"1993","journal-title":"AIDS Inform. Bull."},{"key":"ref_17","unstructured":"(2000). Sentinel Surveillance of the Ministry of Public Health."},{"key":"ref_18","unstructured":"Institut National de la Statistique Enqu\u00eate Demographique et de Sant\u00e9 Cameroun 2004. http:\/\/www.measuredhs.com\/countries\/, accessed April 15, 2008."},{"key":"ref_19","unstructured":"(2005). National AIDS Control Committee\u2019s Annual Reports."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.aids.0000166093.16446.c9","article-title":"Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival","volume":"19","author":"Iliff","year":"2005","journal-title":"AIDS"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-2006-921468","article-title":"Prevention of mother-to-child transmission of HIV in Cameroon: experiences from the University Teaching Hospital in Yaounde (Cameroon)","volume":"128","author":"Kouam","year":"2006","journal-title":"Zentralbl. Gynakol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Musoko, JJ, Macauley, IB, Zoungkanyi, AB, Assumpta, Bella, and Koulla-Shiro, S (2007). Human Immunodeficiency Virus infection and associated factors among specific population subgroups in Cameroon. AIDS Behav, 9294\u20139298.","DOI":"10.1007\/s10461-007-9294-8"},{"key":"ref_23","unstructured":"(Comit\u00e9 National de Lutte contre le SIDA (Groupe Technique Central): Rapport annuel d\u2019activit\u00e9s du Programme National de Lutte contre le SIDA, 2007). Comit\u00e9 National de Lutte contre le SIDA (Groupe Technique Central): Rapport annuel d\u2019activit\u00e9s du Programme National de Lutte contre le SIDA, Yaound\u00e9, Mars 2008."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/5\/5\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:21:18Z","timestamp":1760221278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/5\/5\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,31]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,12]]}},"alternative-id":["ijerph5050378"],"URL":"https:\/\/doi.org\/10.3390\/ijerph5050378","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,31]]}}}